医美茅台涨不动了,“精致男孩”成救命稻草?

花朵财经观察
Nov 06

出品丨花朵财经观察(FF-Finance)撰文丨华见医美行业迎来了“寒意暴击”!2025年三季报季,曾被奉为“医美茅”的爱美客营利双降,华熙生物、昊海生科等头部企业同步陷入双降困境,行业增长逻辑正在改写。当女性消费力趋于理性,医美机构把目光盯向95后男性群体,这场消费转移背后,是行业自救,还是一场倒逼规范的深度调整?PART.01行业失速:从千亿神话到集体滑坡医美行业的暴利神话曾持续多年。上游原料...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10